PMDA drug package insert
タキソテール点滴静注用80mg
PMDA Prescription drug · サノフィ株式会社 · package insert Oct 1, 2026
Key facts
| Brand names | タキソテール点滴静注用80mg, タキソテール点滴静注用20mg |
|---|---|
| Nonproprietary names | ドセタキセル |
| Companies | 製造販売元／サノフィ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | タキソイド系抗悪性腫瘍剤 |
| Therapeutic category codes | 87424 |
| YJ codes | 4240405A2033, 4240405A1037 |
| Approval numbers | 22100AMX01369, 22100AMX01407 |
| Package insert edition | 第7版 |
| Package insert date | Oct 1, 2026 |
| PMDA document key | 780069_4240405A1037_1 |
| PMDA company code | 780069 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: